Oncology Labeling Safety Tips
February 2013 : Oncology - Vol. 10 No. 2 - Page #5

Failure Mode Effects Analysis (FMEA)
Conducting an FMEA can identify opportunities for labeling-related errors. The FMEA should address each step of the process that is impacted by labeling. Begin by observing compounding personnel in the cleanroom. Identify each point in their workflow where a problem could develop. This observation process should span different shifts and staff members to determine procedural consistency.
In addition, observe the stocking and picking processes in action to determine where a mistake is likely to occur. Watch for every step that requires your staff to make a decision as this provides the opportunity for human error to occur. Pay particular attention to:

  • Drugs that are labeled with similar colors
  • Look-alike, sound-alike drugs
  • Clutter in the storage and dispensing areas
  • The potential for drugs to fall from one bin into another
  • The effects of high-volume periods on the pharmacy staff
  • Workflow where multiple products occupy the same work space1

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.